<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">gnck</journal-id><journal-title-group><journal-title xml:lang="ru">Колопроктология</journal-title><trans-title-group xml:lang="en"><trans-title>Koloproktologia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2073-7556</issn><issn pub-type="epub">2686-7303</issn><publisher><publisher-name>Russian Association of Coloproctology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33878/2073-7556-2020-19-3-37-48</article-id><article-id custom-type="elpub" pub-id-type="custom">gnck-1565</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>ПРЕДИКТОРЫ КОЛЭКТОМИИ У ПАЦИЕНТОВ СО СВЕРХТЯЖЕЛЫМ ЯЗВЕННЫМ КОЛИТОМ</article-title><trans-title-group xml:lang="en"><trans-title>PREDICTORS OF COLECTOMY IN PATIENTS WITH «EXTREMELY SEVERE» ULCERATIVE COLITIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ачкасов</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Achkasov</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ул. Саляма Адиля, д. 2, Москва, 123423</p></bio><bio xml:lang="en"><p>Sergey I. Achkasov</p><p>Salyama Adilya str., 2, Moscow, 123423</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шапина</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shapina</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ул. Саляма Адиля, д. 2, Москва, 123423</p></bio><bio xml:lang="en"><p>Marina V. Shapina</p><p>Salyama Adilya str., 2, Moscow, 123423</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Веселов</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Veselov</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ул. Саляма Адиля, д. 2, Москва, 123423</p></bio><bio xml:lang="en"><p>Victor V. Veselov</p><p>Salyama Adilya str., 2, Moscow, 123423</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Варданян</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Vardanyan</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ул. Саляма Адиля, д. 2, Москва, 123423</p></bio><bio xml:lang="en"><p>Armen V. Vardanyan</p><p>Salyama Adilya str., 2, Moscow, 123423</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мингазов</surname><given-names>А. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Mingazov</surname><given-names>A. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мингазов Айрат Фанилевич</p><p>ул. Саляма Адиля, д. 2, Москва, 123423</p></bio><bio xml:lang="en"><p>Airat F. Mingazov</p><p>Salyama Adilya str., 2, Moscow, 123423</p></bio><email xlink:type="simple">info@gnck.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пономаренко</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ponomarenko</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ул. Саляма Адиля, д. 2, Москва, 123423</p></bio><bio xml:lang="en"><p>Alexey A. Ponomarenko</p><p>Salyama Adilya str., 2, Moscow, 123423</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ колопроктологии имени А.Н. Рыжих» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ryzhikh National Medical Research Center of Coloproctology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>21</day><month>09</month><year>2020</year></pub-date><volume>19</volume><issue>3</issue><fpage>37</fpage><lpage>48</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ачкасов С.И., Шапина М.В., Веселов В.В., Варданян А.В., Мингазов А.Ф., Пономаренко А.А., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Ачкасов С.И., Шапина М.В., Веселов В.В., Варданян А.В., Мингазов А.Ф., Пономаренко А.А.</copyright-holder><copyright-holder xml:lang="en">Achkasov S.I., Shapina M.V., Veselov V.V., Vardanyan A.V., Mingazov A.F., Ponomarenko A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ruproctology.com/jour/article/view/1565">https://www.ruproctology.com/jour/article/view/1565</self-uri><abstract><sec><title>ЦЕЛЬ ИССЛЕДОВАНИЯ</title><p>ЦЕЛЬ ИССЛЕДОВАНИЯ: выявить предикторы колэктомии у пациентов со «сверхтяжелой» атакой язвенного колита.</p></sec><sec><title>ПАЦИЕНТЫ И МЕТОДЫ</title><p>ПАЦИЕНТЫ И МЕТОДЫ: проанализированы результаты лечения 74 случаев тяжелой атаки язвенного колита в 2017 году. Пациенты разделены на группы хирургического – 54 и консервативного лечения – 20. Исследовались такие предикторы, как уровень сывороточного альбумина, С – реактивного белка, гемоглобина, эндоскопическая картина и клинические данные.</p></sec><sec><title>РЕЗУЛЬТАТЫ</title><p>РЕЗУЛЬТАТЫ: не выявлено различий по полу, возрасту, длительности заболевания в группах. Средние значения уровня альбумина и гемоглобина были статистически значимо ниже (28 г/л и 96 г/л) в группе колэктомии. Эндоскопическая картина «обширных, сливающихся между собой язвенных дефектов» статистически значимо чаще встречалась у оперированных больных – 78%, по сравнению с 5% в группе консервативного лечения, p&lt;0,0001. Риск колэктомии при наличии эндоскопической картины составил 85%, а при сочетании с уровнем альбумина менее 31 г/л и гемоглобином менее 107 г/л риск повышался до 100%.</p></sec><sec><title>ЗАКЛЮЧЕНИЕ</title><p>ЗАКЛЮЧЕНИЕ: эндоскопическая картина «обширных, сливающихся язвенных дефектов» в сочетании с уровнем альбумина менее 31 г/л и гемоглобина менее 107 г/л являются предикторами колэктомии с высокой прогностической ценностью.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>AIM</title><p>AIM: to identify predictors of colectomy in patients with «extremely severe» ulcerative colitis.</p></sec><sec><title>PATIENTS AND METHODS</title><p>PATIENTS AND METHODS: seventy-four patients with severe ulcerative colitis in 2017 were included in the study. The patients were divided into the groups of colectomy (54 pts) and conservative treatment (20 pts).The predictors such as serum albumin, C-reactive protein, hemoglobin, endoscopic picture, and clinical data were analyzed.</p></sec><sec><title>RESULTS</title><p>RESULTS: the groups were homogeneous by gender, age and duration of the disease. Mean albumin and hemoglobin levels were significantly lower (28 g/l and 96 g/l) in the colectomy group.The endoscopic picture of «extensive ulcer defects merging among themselves» was significantly more common in the operated patients – 78%, compared with 5% in the conservative treatment group (p&lt;0.0001). The risk of colectomy in the presence of an endoscopic picture was 85%, and when combined with an albumin level of less than 31 g/l and hemoglobin of less than 107 g/l, the risk increased to 100%.</p></sec><sec><title>CONCLUSION</title><p>CONCLUSION: the endoscopic picture of «extensive, merging ulcerative defects» in combination with an albumin level of less than 31 g/l and hemoglobin less than 107 g/l are predictors of colectomy with high predictive value.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>язвенный колит</kwd><kwd>колэктомия</kwd><kwd>предикторы колэктомии</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ulcerative colitis</kwd><kwd>colectomy</kwd><kwd>predictors of colectomy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Burisch J, Barros L, et al. Natural disease course of ulcerative colitis during the first five years of follow-up in a European population-based inception cohort – an Epi-IBD study. Journal of Crohn’s and colitis. 2018. DOI: 10.1093/eccojcc/jjy154.</mixed-citation><mixed-citation xml:lang="en">Burisch J, Barros L, et al. Natural disease course of ulcerative colitis during the first five years of follow-up in a European population-based inception cohort – an Epi-IBD study. Journal of Crohn’s and colitis. 2018. DOI: 10.1093/ecco-jcc/jjy154.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Williams JG, Alam MF, et al. Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. Lancet Gastroenterol Hepatol. 2016;1(1):15-24. DOI: 10.1016/S24681253(16)30003-6.</mixed-citation><mixed-citation xml:lang="en">Williams JG, Alam MF, et al. Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. Lancet Gastroenterol Hepatol. 2016;1(1):15-24. DOI: 10.1016/S24681253(16)30003-6.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Merino O, Vera M, et al. Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA Registry. The American Journal of Gastroenterology. 2018;1-8. DOI: 10.1038/s41395-018-0057-0.</mixed-citation><mixed-citation xml:lang="en">Merino O, Vera M, et al. Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA Registry. The American Journal of Gastroenterology. 2018;1-8. DOI: 10.1038/s41395-018-0057-0.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ивашкин В.Т., Шелыгин Ю.А., и соавт. Проект клинических рекомендаций по диагностике и лечению язвенного колита. Колопроктология. 2019; № 4, т. 18, с. 7-36. DOI: 10.33878/20737556-2019-18-4-7-36.</mixed-citation><mixed-citation xml:lang="en">Ivashkin V.T., Shelygin Yu.A. et al. Draft clinical guidelines for the diagnosis and treatment of ulcerative colitis. Koloproktologia. 2019; v. 18, no. 4, pp. 7-36. DOI: 10.33878/2073-7556-2019-18-4-7-36. (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Nguyen GC, Du L, et al. Hypoalbuminaemia and Postoperative Outcomes in Inflammatory Bowel Disease: the NSQIP Surgical Cohort. Journal of Crohn’s and colitis. 2019;1433-8. DOI: 10.1093/ecco-jcc/jjz083.</mixed-citation><mixed-citation xml:lang="en">Nguyen GC, Du L, et al. Hypoalbuminaemia and Postoperative Outcomes in Inflammatory Bowel Disease: the NSQIP Surgical Cohort. Journal of Crohn’s and colitis. 2019;1433-8. DOI: 10.1093/ecco-jcc/jjz083.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Leeds IL, Truta B, et al. Early Surgical Intervention for Acute Ulcerative Colitis Is Associated with Improved Postoperative Outcomes. Journal of Gastrointestinal Surgery. 2017;10(21):16751682. DOI: 10.1007/s11605-017-3538-3.</mixed-citation><mixed-citation xml:lang="en">Leeds IL, Truta B, et al. Early Surgical Intervention for Acute Ulcerative Colitis Is Associated with Improved Postoperative Outcomes. Journal of Gastrointestinal Surgery. 2017;10(21):16751682. DOI: 10.1007/s11605-017-3538-3.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Holubar SD, Soop M, et al. Medical Management of Chronic Ulcerative Colitis. The ASCRS Manual of Colon and Rectal Surgery. 2019;601-616. DOI: 10.1007/978-3-030-01165-9.</mixed-citation><mixed-citation xml:lang="en">Holubar SD, Soop M, et al. Medical Management of Chronic Ulcerative Colitis. The ASCRS Manual of Colon and Rectal Surgery. 2019;601-616. DOI: 10.1007/978-3-030-01165-9.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Harbord M, Eliakim R, et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management. Journal of Crohn’s and Colitis. 2017;12(11):15121512. doi:10.1093/ecco-jcc/jjx009.</mixed-citation><mixed-citation xml:lang="en">Harbord M, Eliakim R, et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management. Journal of Crohn’s and Colitis. 2017;12(11):15121512. doi:10.1093/ecco-jcc/jjx009.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Xie T, Zhang T, et al. Ulcerative Colitis Endoscopic Index of Severity (UCEIS) versus Mayo Endoscopic Score (MES) in guiding the need for colectomy in patients with acute severe colitis. Gastroenterology Report. 2018;1(6):38-44. DOI: 10.1093/gastro/gox016.</mixed-citation><mixed-citation xml:lang="en">Xie T, Zhang T, et al. Ulcerative Colitis Endoscopic Index of Severity (UCEIS) versus Mayo Endoscopic Score (MES) in guiding the need for colectomy in patients with acute severe colitis. Gastroenterology Report. 2018;1(6):38-44. DOI: 10.1093/gastro/gox016.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Dalal RS, Osterman L, et al. A User-Friendly Prediction Tool to Identify Colectomy Risk in Patients With Ulcerative Colitis. Inflammatory Bowel Diseases. 2019;25(9):1550-1558. DOI: 10.1093/ibd/izz014.</mixed-citation><mixed-citation xml:lang="en">Dalal RS, Osterman L, et al. A User-Friendly Prediction Tool to Identify Colectomy Risk in Patients With Ulcerative Colitis. Inflammatory Bowel Diseases. 2019;25(9):1550-1558. DOI: 10.1093/ibd/izz014.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
